(NASDAQ: QURE) Uniqure Nv's forecast annual revenue growth rate of 209.44% is forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 86.2%, and it is also forecast to beat the US market's average forecast revenue growth rate of 10.83%.
Uniqure Nv's revenue in 2025 is $14,337,000.On average, 5 Wall Street analysts forecast QURE's revenue for 2025 to be $2,184,801,153, with the lowest QURE revenue forecast at $921,764,424, and the highest QURE revenue forecast at $6,584,031,600. On average, 5 Wall Street analysts forecast QURE's revenue for 2026 to be $4,698,803,885, with the lowest QURE revenue forecast at $932,737,810, and the highest QURE revenue forecast at $10,424,716,700.
In 2027, QURE is forecast to generate $31,353,707,149 in revenue, with the lowest revenue forecast at $15,686,455,287 and the highest revenue forecast at $47,020,959,010.